Xarelto and Ingrezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xarelto (rivaroxaban) and Ingrezza (valbenazine tosylate). Common drug interactions include fall among females and somnolence among males.

The phase IV clinical study analyzes what interactions people have when they take Xarelto and Ingrezza. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 212,377 Xarelto users. Check the latest studies of Xarelto.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

On Jul, 23, 2026

50 people who take Xarelto and Ingrezza together, and have interactions are studied.

What are the common drug interactions of Xarelto and Ingrezza, by gender? *:

female:

Fall
Somnolence (a state of near-sleep, a strong desire for sleep)
Arthralgia (joint pain)
Pruritus generalised (generalized itching)
Dry mouth
Gingival erosion (gum ulcer)
Urinary tract infection
Dizziness
Memory impairment
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

male:

Somnolence (a state of near-sleep, a strong desire for sleep)
Back pain
Anxiety
Blood pressure decreased
Fatigue (feeling of tiredness)
Hospitalisation
Insomnia (sleeplessness)
Rehabilitation therapy
Cardiac arrest
Coronary artery bypass

What are the common drug interactions of Xarelto and Ingrezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Headache (pain in head)
Neck pain

50-59:

Fall
Memory impairment
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
Adverse drug reaction
Balance disorder
Dizziness
Dyskinesia (abnormality or impairment of voluntary movement)
Nausea (feeling of having an urge to vomit)

60+:

Somnolence (a state of near-sleep, a strong desire for sleep)
Fall
Cough
Disturbance in attention
Dizziness
Dyspnoea (difficult or laboured respiration)
Feeling jittery
Ligament sprain (ligament stretched)
Neck pain
Oedema (fluid collection in tissue)

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 37 people, 74.00%
Stress And Anxiety: 8 people, 16.00%
Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 8.00%
Sleep Disorder: 3 people, 6.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.00%
Depression: 3 people, 6.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Xarelto and Ingrezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously